Glaucoma Clinical Trials

Post Approval Study of the CyPass System

Conditions:   Primary Open-angle Glaucoma;   Cataract
Intervention:   Device: CyPass Micro-Stent implanted with CyPass 241-S applier
Sponsor:   Alcon Research
Not yet recruiting

Learn More

A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Conditions:   Glaucoma, Open-angle;   Ocular Hypertension
Interventions:   Drug: 0.01% RO7058584;   Drug: 0.1% RO7058584;   Drug: 1% RO7058584;   Drug: Matching Placebo;   Drug: Latanoprost 0.005%
Sponsor:   Hoffmann-La Roche

Learn More

Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma

Conditions:   Retinoblastoma;   Cataracts Infantile;   Glaucoma, Congenital;   Leucocoria
Interventions:   Other: CRADLE;   Other: Red reflex testing
Sponsor:   St. Jude Children's Research Hospital

Learn More

Human Optokinetic Contrast Device (HOCD) to Measure Visual Function and Identify Patients With and Without Glaucoma (HOCD)

The purpose of this study is to determine if an optokinetic contrast detection device is sufficient to measure contrast sensitivity and to distinguish between patients with and without glaucoma.

Learn More

Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration

This is a randomized, sham controlled, masked clinical trial of 60 study participants with glaucoma. Participants with a qualifying study eye will be randomized after screening and baseline evaluations to receive the NT-501 encapsulated cell thera...

Learn More

1-5 of 5
Results per page

Join the community!

You must be a member of healtheo360 in order to view this group

Register with Email Address

Already a member? Click here to login

healtheo360 believes strongly in user privacy.